197 related articles for article (PubMed ID: 20442768)
1. Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.
Labalette C; Nouët Y; Levillayer F; Colnot S; Chen J; Claude V; Huerre M; Perret C; Buendia MA; Wei Y
PLoS One; 2010 Apr; 5(4):e10371. PubMed ID: 20442768
[TBL] [Abstract][Full Text] [Related]
2. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
3. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
[TBL] [Abstract][Full Text] [Related]
4. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
Nouët Y; Dahan J; Labalette C; Levillayer F; Julien B; Jouvion G; Cairo S; Vives FL; Ribeiro A; Huerre M; Colnot S; Perret C; Nhieu JT; Tordjmann T; Buendia MA; Wei Y
J Hepatol; 2012 Nov; 57(5):1029-36. PubMed ID: 22796152
[TBL] [Abstract][Full Text] [Related]
5. The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation.
Labalette C; Nouët Y; Sobczak-Thepot J; Armengol C; Levillayer F; Gendron MC; Renard CA; Regnault B; Chen J; Buendia MA; Wei Y
J Biol Chem; 2008 May; 283(22):15201-8. PubMed ID: 18378678
[TBL] [Abstract][Full Text] [Related]
6. Deletion of FHL2 in fibroblasts attenuates fibroblasts activation and kidney fibrosis via restraining TGF-β1-induced Wnt/β-catenin signaling.
Duan Y; Qiu Y; Huang X; Dai C; Yang J; He W
J Mol Med (Berl); 2020 Feb; 98(2):291-307. PubMed ID: 31927599
[TBL] [Abstract][Full Text] [Related]
7. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
8. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
9. Identification of the LIM protein FHL2 as a coactivator of beta-catenin.
Wei Y; Renard CA; Labalette C; Wu Y; Lévy L; Neuveut C; Prieur X; Flajolet M; Prigent S; Buendia MA
J Biol Chem; 2003 Feb; 278(7):5188-94. PubMed ID: 12466281
[TBL] [Abstract][Full Text] [Related]
10. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
11. The roles of FHL2 in cancer.
Zhang J; Zeng Q; She M
Clin Exp Med; 2023 Nov; 23(7):3113-3124. PubMed ID: 37103649
[TBL] [Abstract][Full Text] [Related]
12. The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcription.
Renger A; Zafiriou MP; Noack C; Pavlova E; Becker A; Sharkova K; Bergmann MW; El-Armouche A; Zimmermann WH; Zelarayán LC
Stem Cells; 2013 May; 31(5):928-40. PubMed ID: 23341242
[TBL] [Abstract][Full Text] [Related]
13. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
[TBL] [Abstract][Full Text] [Related]
14. FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating β-catenin signalling.
Cai T; Sun D; Duan Y; Qiu Y; Dai C; Yang J; He W
J Cell Mol Med; 2018 Mar; 22(3):1684-1695. PubMed ID: 29193729
[TBL] [Abstract][Full Text] [Related]
15. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
Li M; Wang J; Ng SS; Chan CY; Chen AC; Xia HP; Yew DT; Wong BC; Chen Z; Kung HF; Lin MC
Glia; 2008 Sep; 56(12):1328-38. PubMed ID: 18615633
[TBL] [Abstract][Full Text] [Related]
16. The role of FHL2 in wound healing and inflammation.
Wixler V
FASEB J; 2019 Jul; 33(7):7799-7809. PubMed ID: 30939249
[TBL] [Abstract][Full Text] [Related]
17. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins.
Park J; Will C; Martin B; Gullotti L; Friedrichs N; Buettner R; Schneider H; Ludwig S; Wixler V
FASEB J; 2008 Jul; 22(7):2508-20. PubMed ID: 18356303
[TBL] [Abstract][Full Text] [Related]
19. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
[TBL] [Abstract][Full Text] [Related]
20. Matrix mechanics controls FHL2 movement to the nucleus to activate p21 expression.
Nakazawa N; Sathe AR; Shivashankar GV; Sheetz MP
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6813-E6822. PubMed ID: 27742790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
